Regulating Pharmaceutical Prices in India: Policy Design, Implementation and Compliance (India Studies in Business and Economics) - Image 1

£82.73

Springer Regulating Pharmaceutical Prices in India: Policy Design, Implementation and Compliance (India Studies in Business and Economics)

Name: Regulating Pharmaceutical Prices in India: Policy Design, Implementation and Compliance (India Studies in Business and Economics)
Brand: Springer
Price: 82.73 GBP
Availability: InStock

International

About as cheap as it gets. The only time it was cheaper was 9 months ago.

£83 today · all-time low £79 (Sep 2025) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 208 days • 208 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 208 days • 4 price levels

Days at Price

Current Price

Price Analysis

Most common price: £79 (140 days, 67.3%)

Price range: £79 - £84

Price levels: 4 different prices over 208 days

Description

This book presents an extensive study on the effectiveness of recent regulations on pharmaceutical prices in India, exploring the weaknesses in the design and implementation of pharmaceutical price controls and investigating what can be done to fix the broken system. In addition, it examines the extent to which essential medicines are actually made affordable by price controls. The book argues that companies make the pharmaceutical price control regime largely ineffective by coordinating to increase pre-regulation prices; by diversifying horizontally away from the regulated markets and increasing prices in the unregulated markets; by manipulating trade margins; and by refusing to comply with the regulation because the penalties remains negligible. The book draws on extensive empirical research involving India’s 2013 Drug Price Control Order and widely-used medicines such as paracetamol and metformin to illustrate how firms have weakened regulation. It argues that the regulatory regime can be strengthened by using systematic analysis of product- and region-level data in the Indian pharmaceutical industry, and by screening for the strategies that firms currently employ to circumvent regulation. In closing, it discusses recent efforts to strengthen the implementation of price controls in India and expanding the scope of price controls to medical devices. From the Back Cover This book presents an extensive study on the effectiveness of recent regulations on pharmaceutical prices in India, exploring the weaknesses in the design and implementation of pharmaceutical price controls and investigating what can be done to fix the broken system. In addition, it examines the extent to which essential medicines are actually made affordable by price controls. The book argues that companies make the pharmaceutical price control regime largely ineffective by coordinating to increase pre-regulation prices; by diversifying horizontally away from the regulated markets and increasing prices in the unregulated markets; by manipulating trade margins; and by refusing to comply with the regulation because the penalties remains negligible. The book draws on extensive empirical research involving India’s 2013 Drug Price Control Order and widely-used medicines such as paracetamol and metformin to illustrate how firms have weakened regulation. It argues that the regulatory regime can be strengthened by using systematic analysis of product- and region-level data in the Indian pharmaceutical industry, and by screening for the strategies that firms currently employ to circumvent regulation. In closing, it discusses recent efforts to strengthen the implementation of price controls in India and expanding the scope of price controls to medical devices. About the Author Ajay Bhaskarabhatla is an associate professor at Erasmus School of Economics, The Netherlands. Ajay’s research on the Indian pharmaceutical industry has been published in top peer-reviewed journals.

Product Specifications

Brand: Springer
Format: Paperback
ASIN: 3030066525
Category: Books > Subjects > Business, Finance & Law > Accounting > International
Domain: Amazon UK
Release Date: 30 January 2019
Listed Since: 30 January 2019

Barcode

No barcode data available

Springer Regulating Pharmaceutical Prices in India: Policy Design, Implementation and Compliance (India Studies in Business and Economics)

About as cheap as it gets. The only time it was cheaper was 9 months ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Regulating Pharmaceutical Prices in India: Policy Design, Implementation and Compliance (India Studies in Business and Economics)

Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health

Global Pharmaceutical Policy

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Government, Big Pharma, and The People: A Century of Dis-Ease

Pharmacoeconomics: From Theory to Practice

Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

PHARMACEUTICAL ECONOMICS AND POLICY 3RD EDITION: Perspectives, Promises, and Problems

Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)

Pharmacoeconomics: From Theory to Practice

EU Law of Competition and Trade in the Pharmaceutical Sector (Elgar Competition Law and Practice series)

The Price of Global Health: Drug Pricing Strategies to Balance Patient Access and the Funding of Innovation

The Pharmaceutical Industry: A Guide to Historical Records (Studies in British Business Archives)

World Pharmaceutical Industry

Medicine Price Surveys, Analyses and Comparisons: Evidence and Methodology Guidance

Essentials of Pharmacoeconomics: Health Economics and Outcomes Research

Routledge Pharmaceutical Industry and Public Policy in India

Understanding Drugs Markets: An Analysis of Medicines, Regulations and Pharmaceutical Systems in the Global South (Routledge Studies in the Sociology of Health and Illness)

The 2023-2028 Outlook for Bioengineered Monoclonal Antibodies Protein Drugs in Japan

Pharmaceuticals, Corporate Crime and Public Health

Blankettstrafgesetze und ihre verfassungsrechtlichen Grenzen: 1 (Juridicum - Schriften zum Wirtschaftsstrafrecht, 1)

Pharmaceutical Public Policy